Skip to content

NAOV

ENvue Medical, Inc.

NASDAQ · Healthcare · Medical - Devices · US

$1.90
+1.06%
Ask drillr

Year over year

Reported trailing growth

Revenue
-18.4%
EBITDA
—
EBIT
—
EPS
+17.1%
Free cash flow
—
Operating cash flow
—

Forward estimates

Based on analyst estimates

Revenue
—
EBITDA
—
EPS
—

Three-year CAGR

Revenue
+14.7%
EBITDA
-3.9%
EBIT
-4.2%
Net income
+0.2%
EPS
+35.2%
Free cash flow
+30.1%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026